Skip to main content
PYXS
NASDAQ Life Sciences

Analyst Flags Safety Risks in Pyxis Oncology's Cancer Drug, Shares Drop 9%

Tom Rudovsky · Reported by Benzinga
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$3.5
Mkt Cap
$291.928M
52W Low
$1.03
52W High
$5.55
52W Position info
240% above low
Off High info
37% below high
Rel. Volume info
2.8× avg
Market data snapshot near publication time

PYXS has more than doubled off its 52-week low of $1.03 on elevated volume (2.8× avg).

Summary

William Blair analyst Andy Hsieh called MICVO's safety profile a key liability despite encouraging efficacy, noting 54% of patients had grade 3+ treatment-related adverse events and 14% discontinued. The stock fell 9.25% to $3.53 as the market weighed the safety concerns against the 36% confirmed response rate. This follows the company's earlier release of the same Phase 1 data, but the analyst's negative safety framing and the sharp price drop are new developments. The company plans an FDA meeting in Q1 2027 to finalize dosing, with a Phase 3 trial expected to start mid-2027.

At the time of this announcement, PYXS was trading at $3.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $291.9M. The 52-week trading range was $1.03 to $5.55. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 19, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.80 info
Change: +$0.300 (+20%) info
Market Cap: $215.294M info
PYXS
Nov 18, 2026, 6:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.80 info
Change: +$0.340 (+23%) info
Market Cap: $215.294M info
PYXS
Nov 13, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.80 info
Change: +$0.220 (+14%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info